Rebekka Hueting

ORCID: 0000-0002-3732-9243
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Radiopharmaceutical Chemistry and Applications
  • Lanthanide and Transition Metal Complexes
  • Medical Imaging Techniques and Applications
  • PARP inhibition in cancer therapy
  • Metal complexes synthesis and properties
  • Cancer, Hypoxia, and Metabolism
  • Chemical Reactions and Isotopes
  • Magnetism in coordination complexes
  • Fluorine in Organic Chemistry
  • DNA Repair Mechanisms
  • Atomic and Subatomic Physics Research
  • Advanced MRI Techniques and Applications
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Radiation Therapy and Dosimetry
  • S100 Proteins and Annexins
  • Organometallic Compounds Synthesis and Characterization
  • Cell death mechanisms and regulation
  • Click Chemistry and Applications
  • Immune Response and Inflammation
  • Epilepsy research and treatment
  • Radioactive element chemistry and processing
  • Metalloenzymes and iron-sulfur proteins
  • Trace Elements in Health
  • Acute Myocardial Infarction Research

University of Oxford
2008-2022

CRUK/MRC Oxford Institute for Radiation Oncology
2008-2022

University Hospital of Wales
2022

Cardiff University
2021-2022

Churchill Hospital
2020

King's College London
2013-2017

Oxfam
2014-2015

Oxford Research Group
2014

St Thomas' Hospital
2013-2014

University of Surrey
2013

Background Systemic cancer spread is preceded by the establishment of a permissive microenvironment in target tissue metastasis -the premetastatic niche.As crucial players pre-metastatic niche, myeloid derived suppressor cells (MDSC) release S100A8/A9, an exosomal protein that contributes to metastasis, angiogenesis, and immune suppression.We report application antibody-based single-photon emission computed tomography (SPECT) for detection S100A8/A9 vivo as imaging marker priming.Methods A...

10.7150/thno.17138 article EN cc-by Theranostics 2017-01-01

Poly(ADP-ribose) polymerase (PARP) inhibitors are increasingly being studied as cancer drugs, single agents, or a part of combination therapies. Imaging PARP using radiolabeled inhibitor has been proposed for patient selection, outcome prediction, dose optimization, genotoxic therapy evaluation, and target engagement imaging novel PARP-targeting agents. <b>Methods:</b> Here, via the copper-mediated <sup>18</sup>F-radiofluorination aryl boronic esters, we accessed, first time (to our...

10.2967/jnumed.118.213223 article EN cc-by Journal of Nuclear Medicine 2018-11-02

<sup>64</sup>Cu-diacetyl-bis(<i>N</i><sup>4</sup>-methylthiosemicarbazonate), <sup>64</sup>Cu-ATSM, continues to be investigated clinically as a PET agent both for delineation of tumor hypoxia and an effective indicator patient prognosis, but there are still aspects the mechanism action that not fully understood. <b>Methods:</b> The retention radioactivity in tumors after administration <sup>64</sup>Cu-ATSM vivo is substantially higher with significant hypoxic fraction. This...

10.2967/jnumed.113.119917 article EN Journal of Nuclear Medicine 2013-12-12

A range of new carboxylate functionalised bis(thiosemicarbazone) ligands and their Cu(II) complexes have been prepared, fully characterised radiolabeled in high yield with both 64Cu 99mTc. Conjugation to a bombesin derivative was achieved using standard solid phase synthetic methodologies the 64Cu-labeled conjugate shown good tumour uptake mice xenografted PC-3 tumours.

10.1039/b925128f article EN Dalton Transactions 2010-01-01

A water-soluble glucose conjugate of the hypoxia tracer <sup>64</sup>Cu-diacetyl-bis(<i>N</i><sup>4</sup>-methylthiosemicarbazone) (<sup>64</sup>Cu-ATSM) was synthesized and radiolabeled (<sup>64</sup>Cu-ATSE/A-G). Here we report our initial biological experiments with <sup>64</sup>Cu-ATSE/A-G compare results those obtained for <sup>64</sup>Cu-ATSM <sup>18</sup>F-FDG. <b>Methods:</b> The uptake into HeLa cells in vitro investigated at a range dissolved oxygen concentrations representing...

10.2967/jnumed.108.054015 article EN Journal of Nuclear Medicine 2008-10-16

Background Preclinical imaging requires anaesthesia to reduce motion-related artefacts. For direct translational relevance, must not significantly alter experimental outcome. This study reports on the effects of both anaesthetic and carrier gas upon uptake [64Cu]-CuATSM, [99mTc]-HL91 [18F]-FMISO in a preclinical model tumor hypoxia. Methodology/Principal Findings The effect was studied 6 groups CaNT-bearing CBA mice using or [18F]-FMISO. Mice were anaesthetised with isoflurane air, pure...

10.1371/journal.pone.0025911 article EN cc-by PLoS ONE 2011-11-15

Pyrene-appended ytterbium complexes have been prepared using Ugi reactions to vary the chromophore-lanthanide separation. Formation of ytterbium(iii) excited state is sensitised via both singlet and triplet states chromophore. Energy transfer from latter relatively slow, gives rise oxygen-dependent luminescence.

10.1039/c5cc06891f article EN Chemical Communications 2015-01-01

Oxygen dependent luminescence in pyrene appended europium complexes is shown to arise two different ways. The nature of the pathway can be controlled by varying lanthanide–pyrene separation.

10.1039/c4ra09271f article EN RSC Advances 2014-01-01

Flumazenil (FMZ) is a functionally silent imidazobenzodiazepine which binds to the benzodiazepine binding site of approximately 75% brain γ-aminobutyric acid-A receptors (GABAARs). Positron Emission Tomography (PET) imaging GABAARs with [11C]FMZ has been used evidence alterations in neuronal density, assess target engagement novel pharmacological agents, and study disorders such as epilepsy Huntington's disease. Despite potential FMZ PET short half-life (t1/2) carbon-11 (20 min) limited more...

10.1186/s41181-022-00158-z article EN cc-by EJNMMI Radiopharmacy and Chemistry 2022-03-20

Abstract The synthesis of zinc(II) and copper(II) complexes an unsymmetrical bis(thiosemicarbazonato) ligand containing a reactive styrene group are reported. compounds have been characterised by range techniques including reverse‐phase HPLC, cyclic voltammetry, NMR, UV/Vis, electron paramagnetic resonance fluorescence emission spectroscopy. Time‐dependent density functional theory calculations used to assign the electronic absorption spectrum [Zn II ATSM] probe nature fluorescent excited...

10.1002/ejic.200701351 article EN European Journal of Inorganic Chemistry 2008-03-10

Copper(ii)bis(thiosemicarbazonato) complexes such as [64Cu]Cu-ATSM continue to be investigated for positron emission tomography (PET) imaging of tumour hypoxia. However, the currently proposed mechanisms mode action these are unable account fully their observed biological behaviour. In order examine roles copper metal and ligand, we designed a pair 123I/64Cu-copper bis(thiosemicarbazonates), radiolabelled at either or ligand. vitro cellular retention studies orthogonal demonstrate first time...

10.1039/c4mt00330f article EN Metallomics 2015-01-01

Abstract Purpose Radiopharmaceuticals targeting poly(ADP-ribose) polymerase (PARP) have emerged as promising agents for cancer diagnosis and therapy. PARP enzymes are expressed in both cancerous normal tissue. Hence, the injected mass, molar activity potential pharmacological effects important considerations use of radiolabelled inhibitors diagnostic radionuclide therapeutic applications. Here, we performed a systematic evaluation by varying [ 18 F]olaparib mass Total to investigate on...

10.1186/s13550-022-00940-9 article EN cc-by EJNMMI Research 2022-10-09

Poly (ADP-ribose) polymerase (PARP) inhibitors are extensively studied and used as anti-cancer drugs, single agents or in combination with other therapies. Most radiotracers developed to date have been chosen on the basis of strong PARP1-3 affinity. Herein, we propose study AZD2461, a PARP inhibitor lower affinity towards PARP3, investigate its potential for targeting vivo.

10.1007/s11307-020-01497-6 article EN cc-by Molecular Imaging and Biology 2020-04-27

The synthesis of three pairs orthogonally labelled fluorinated Cu bis(thiosemicarbazonato) complexes is presented. These are the first examples (18)F-labelled Cu(II)-complexes designed to serve as new hypoxia selective PET tracers and mechanistic probes study mode action this class markers. In vitro evaluation revealed that Cu-complex derived from amide coupling suitable for in vivo work.

10.1039/b926980k article EN Chemical Communications 2010-01-01

Meeting Summary The 21st annual symposium of the International Isotope Society's United Kingdom Group took place at Møller Centre, Churchill College, Cambridge, UK, on Friday 12th October 2012. meeting was attended by around 60 delegates from academia and industry, life sciences, chemical, radiochemical scientific instrument suppliers. Delegates were welcomed Dr Ken Lawrie (GlaxoSmithKline, chair IIS UK group). subsequent programme consisted oral poster presentations isotopic chemistry...

10.1002/jlcr.3015 article EN Journal of Labelled Compounds and Radiopharmaceuticals 2013-02-01

Ataxia telangiectasia mutated (ATM) is a key mediator of the DNA damage response, and several ATM inhibitors (ATMi) are currently undergoing early phase clinical trials for treatment cancer. A radiolabelled ATMi to determine drug pharmacokinetics could assist patient selection in move towards more personalised medicine. The aim this study was synthesise investigate first 18F-labelled inhibitor [18F]1 non-invasive imaging protein pharmacokinetics. Radiofluorination confirmed selective (1)...

10.1186/s13550-022-00920-z article EN cc-by EJNMMI Research 2022-08-13
Coming Soon ...